{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:53:25Z","timestamp":1785704005904,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2023YFC2706301"],"award-info":[{"award-number":["2023YFC2706301"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.04.023","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:25:13Z","timestamp":1777735513000},"page":"978.e1-978.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in X-Linked Hyper IgM Syndrome: A Multicenter Chinese Cohort Study from CCBMT"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4391-3398","authenticated-orcid":false,"given":"Uet","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2895-700X","authenticated-orcid":false,"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.04.023_bib0001","unstructured":"Dunn CP, de la Morena MT. X-linked hyper IgM syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews(\u00ae). University of Washington, Seattle, WA."},{"key":"10.1016\/j.jtct.2026.04.023_bib0002","series-title":"GeneReviews is a Registered Trademark of the University of Washington, Seattle. All Rights Reserved","year":"1993"},{"key":"10.1016\/j.jtct.2026.04.023_bib0003","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12016-013-8378-7","article-title":"The hyper IgM syndromes","volume":"46","author":"Qamar","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0004","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10875-013-9951-9","article-title":"Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients","volume":"33","author":"Al-Saud","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0005","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s10875-016-0291-4","article-title":"Hyper IgM syndrome: a report from the USIDNET registry","volume":"36","author":"Leven","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0006","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2016.07.039","article-title":"Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation","volume":"139","author":"de la Morena","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0007","series-title":"StatPearls","article-title":"Immunodeficiency Disorders (Primary and Secondary)","volume":"26","author":"Justiz Vaillant","year":"2023"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2026.04.023_bib0009","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/bmt.2008.121","article-title":"Hematopoietic cell transplantation for correction of primary immunodeficiencies","volume":"42","author":"Filipovich","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.04.023_bib0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/1744666X.2019.1573674","article-title":"CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives","volume":"15","author":"Fran\u00e7a","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0011","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/asheducation.V2000.1.319.319","article-title":"Bone marrow transplantation for non-malignant disease","author":"Sullivan","year":"2000","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtct.2026.04.023_bib0012","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-3476(03)00274-9","article-title":"Outcome of hematopoietic stem cell transplantation in hyper-IgM syndrome caused by CD40 deficiency","volume":"143","author":"Kutukculer","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jtct.2026.04.023_bib0013","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ajh.20044","article-title":"Allogeneic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: a single center experience","volume":"76","author":"Tomizawa","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0014","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jaci.2018.12.1010","article-title":"Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT\/ESID-IEWP-SCETIDE-PIDTC study","volume":"143","author":"Ferrua","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0015","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4103\/1319-2442.121269","article-title":"Mismatched related hematopoietic stem cell transplantation in primary immunodeficiency","volume":"24","author":"Wahadneh","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.jtct.2026.04.023_bib0016","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1111\/j.1399-3046.2012.01786.x","article-title":"Successful haploidentical PBSCT with subsequent T-cell addbacks in a boy with HyperIgM syndrome presenting as severe congenital neutropenia","volume":"17","author":"Jasinska","year":"2013","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2026.04.023_bib0017","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s10875-021-00966-z","article-title":"Hematopoietic cell transplantation with reduced intensity conditioning using fludarabine\/busulfan or fludarabine\/melphalan for primary immunodeficiency diseases","volume":"41","author":"Nishimura","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0018","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12887-019-1729-7","article-title":"Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center","volume":"19","author":"Wu","year":"2019","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jtct.2026.04.023_bib0019","first-page":"830","article-title":"[Unrelated umbilical cord blood stem cell transplantation in the treatment of hyper-IgM syndrome caused by CD40 ligand gene mutation: a report of three cases and literature review]","volume":"59","author":"Wang","year":"2021","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.jtct.2026.04.023_bib0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13045-020-00860-y","article-title":"Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study","volume":"13","author":"Chang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/cyto.a.22520","article-title":"Lymphocytes subsets reference values in childhood","volume":"87","author":"Tosato","year":"2015","journal-title":"Cytometry A"},{"key":"10.1016\/j.jtct.2026.04.023_bib0022","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1590\/s1679-45082011ao2007","article-title":"Allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiencies: Hospital Israelita Albert Einstein experience","volume":"9","author":"Fernandes","year":"2011","journal-title":"Einstein (Sao Paulo)"},{"key":"10.1016\/j.jtct.2026.04.023_bib0023","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2017.06.036","article-title":"Liver disease predicts mortality in patients with X-linked immunodeficiency with hyper-IgM but can be prevented by early hematopoietic stem cell transplantation","volume":"141","author":"Azzu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0024","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jaci.2015.02.020","article-title":"Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan","volume":"136","author":"Mitsui-Sekinaka","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0025","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/petr.12538","article-title":"Hematopoietic stem cell transplant for hyper-IgM syndrome due to CD40L defects: a single-center experience","volume":"19","author":"Al-Saud","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2026.04.023_bib0026","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1002\/pbc.25711","article-title":"Hematopoietic stem cell transplantation for CD40 ligand deficiency: single institution experience","volume":"62","author":"Allewelt","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2026.04.023_bib0027","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bmt.1705273","article-title":"Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team","volume":"37","author":"Tsuji","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.04.023_bib0028","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.bmt.1705511","article-title":"Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction","volume":"38","author":"Kikuta","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.04.023_bib0029","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10875-023-01633-1","article-title":"Clinical and immunological features, genetic variants, and outcomes of patients with CD40 deficiency","volume":"44","author":"Banday","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpeds.2019.01.015","article-title":"Chronic cholangiopathy associated with primary immune deficiencies can be resolved by effective hematopoietic stem cell transplantation","volume":"209","author":"Had\u017ei\u0107","year":"2019","journal-title":"J Pediatr"},{"key":"10.1016\/j.jtct.2026.04.023_bib0031","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.jaci.2018.12.1013","article-title":"Combined liver and hematopoietic stem cell transplantation in patients with X-linked hyper-IgM syndrome","volume":"143","author":"Bucciol","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0032","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/TP.0000000000002114","article-title":"Successful sequential liver and hematopoietic stem cell transplantation in a child with CD40 ligand deficiency and cryptosporidium-induced liver cirrhosis","volume":"102","author":"Quarello","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2026.04.023_bib0033","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.bbmt.2012.11.007","article-title":"Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India","volume":"19","author":"Choudhary","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.04.023_bib0034","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000087895","article-title":"Donor lymphocyte infusion can eliminate mixed chimerism in nonmyeloablative stem cell transplantation for correction of hyper-IgM syndrome","volume":"114","author":"Hongeng","year":"2005","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41409-018-0219-0","article-title":"Haematopoietic stem cell transplant for hyper-IgM syndrome due to CD40 defects: a single-centre experience","volume":"54","author":"Al-Saud","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.04.023_bib0036","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1186\/s12887-022-03726-z","article-title":"Respiratory infections in X-linked hyper-IgM syndrome with CD40LG mutation: a case series of seven children in China","volume":"22","author":"Fan","year":"2022","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jtct.2026.04.023_bib0037","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2016.18","article-title":"Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients","volume":"5","author":"Chan","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jtct.2026.04.023_bib0038","doi-asserted-by":"crossref","first-page":"297","DOI":"10.47102\/annals-acadmedsg.V44N8p297","article-title":"Disseminated bacillus Calmette-Gu\u00e9rin and susceptibility to mycobacterial infections-implications on bacillus Calmette-Gu\u00e9rin vaccinations","volume":"44","author":"Lee","year":"2015","journal-title":"Ann Acad Med Singap"},{"key":"10.1016\/j.jtct.2026.04.023_bib0039","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13213","article-title":"A single-center study points to diverse features and outcome in patients with hyperimmunoglobulin M syndrome and class\u2014Switch recombination defects","volume":"96","author":"Akarsu","year":"2022","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0040","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaip.2018.09.004","article-title":"Comparison of common monogenic defects in a large predominantly antibody deficiency cohort","volume":"7","author":"Yazdani","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jtct.2026.04.023_bib0041","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clim.2018.11.007","article-title":"The hyper IgM syndromes: epidemiology, pathogenesis, clinical manifestations, diagnosis and management","volume":"198","author":"Yazdani","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0042","article-title":"An X-linked hyper-IgM patient followed successfully for 23 years without hematopoietic stem cell transplantation","volume":"2018","author":"Kutukculer","year":"2018","journal-title":"Case Rep Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101297","article-title":"DNA-PK inhibition enhances gene editing efficiency in HSPCs for CRISPR-based treatment of X-linked hyper IgM syndrome","volume":"32","author":"Pugliano","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jtct.2026.04.023_bib0044","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12967-023-04374-2","article-title":"Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models","volume":"21","author":"Wenthe","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.jtct.2026.04.023_bib0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/bjh.17070","article-title":"T cell gene therapy to treat immunodeficiency","volume":"192","author":"Panchal","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0046","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.molimm.2018.11.018","article-title":"A tetrameric form of CD40 ligand with potent biological activities in both mouse and human primary B cells","volume":"105","author":"Lai","year":"2019","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0047","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clim.2012.01.014","article-title":"CD40 agonist antibody mediated improvement of chronic cryptosporidium infection in patients with X-linked hyper IgM syndrome","volume":"143","author":"Fan","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtct.2026.04.023_bib0048","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jmii.2012.07.004","article-title":"X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients","volume":"48","author":"Tsai","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jtct.2026.04.023_bib0049","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/683160","article-title":"Clinical features and genetic analysis of 20 Chinese patients with X-linked hyper-IgM syndrome","volume":"2014","author":"Wang","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jtct.2026.04.023_bib0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-3083.2010.02406.x","article-title":"Clinical and molecular characterization of X-linked hyper-IgM syndrome patients in China","volume":"72","author":"An","year":"2010","journal-title":"Scand J Immunol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600309X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600309X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:11:53Z","timestamp":1785701513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672600309X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S266663672600309X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.023","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in X-Linked Hyper IgM Syndrome: A Multicenter Chinese Cohort Study from CCBMT","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}